OverviewSuggest Edit

    NeuroQore is set to commercialize a new patented monophasic repetitive transcranial magnetic stimulation (rTMS) system with a potentially improved remission rate. The first unit of the NeuroQore rTMS system was installed at the Royal Ottawa Mental Health Centre in July 2015 and successfully passed tolerability testing on healthy volunteers in a pilot project. The company is now in the midst of recruiting patients for the next round of testing. Preliminary clinical data is promising and has prompted installation of more units to recruit more patients faster.
    Repetitive transcranial magnetic stimulation (rTMS) is an emerging therapeutic brain stimulation technique that does not require anesthesia, has no cognitive side effects, and is widely accepted by patients. rTMS is currently administered by a technician or nurse in an outpatient clinical setting. The potency and efficacy of conventional biphasic rTMS (45-55% response, 30-35% remission) falls between medications and ECT, but rTMS offers the advantages of high tolerability and accessibility.
    NeuroQore monophasic rTMS system with an improved remission rate has potential to be a disruptive innovation that results in improved health care worldwide. NeuroQore is looking to effectively integrate into existing health-care facilities and coordinated with ongoing treatments as a complement to medications and therapy.

    HQOttawa, CA


    NeuroQore is headquartered in
    Ottawa, Canada

    Location Map

    Latest Updates

    Employees (est.) (Oct 2020)3
    Cybersecurity ratingAMore

    Key People/Management at NeuroQore

    Mehran Talebinejad

    Mehran Talebinejad


    NeuroQore Office Locations

    NeuroQore has offices in Ottawa, Newport Beach and San Francisco
    Newport Beach, US
    Newport Beach, CA, USA
    San Francisco, US
    San Francisco
    Show all (3)

    NeuroQore Financials and Metrics

    Summary Metrics

    Founding Date


    Time since last funding

    4 years ago

    NeuroQore investors

    Show all financial metrics

    NeuroQore Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    NeuroQore Online and Social Media Presence

    Embed Graph

    NeuroQore Frequently Asked Questions

    • When was NeuroQore founded?

      NeuroQore was founded in 2011.

    • Who are NeuroQore key executives?

      NeuroQore's key executives are Mehran Talebinejad.

    • How many employees does NeuroQore have?

      NeuroQore has 3 employees.

    • Who are NeuroQore competitors?

      Competitors of NeuroQore include Seno Medical instruments, GoHealth Urgent Care and Mauna Kea Technologies.

    • Where are NeuroQore offices?

      NeuroQore has offices in Ottawa, Newport Beach and San Francisco.

    • How many offices does NeuroQore have?

      NeuroQore has 3 offices.